Long-lasting enhancement of CYP activity after discontinuation of repeated administration of phenobarbital in dogs.
We investigated how long in vivo hepatic cytochrome P450 (CYP) activity is enhanced even after discontinuation of repeated oral administration of phenobarbital (PB) in dogs using antipyrine clearance, which reflects hepatic CYP activity. A single antipyrine (5 mg/kg) was administered intravenously before and 34 days after the repeated oral administration of PB (5 mg/kg, bid) and 2, 4, 6, and 8 weeks after the discontinuation of PB in 5 dogs. Antipyrine clearance was increased by the repeated administration of PB, and remained increased 2 and 4, but not 6 and 8 weeks after the discontinuation of PB. The result suggests that hepatic CYP activity was enhanced by the repeated administration of PB, and this enhancement may last for at least 4 weeks even after its discontinuation.
Fukunaga
K
K
Department of Pharmacology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 229-8501, Japan.
Saito
M
M
Matsuo
E
E
Muto
M
M
Mishima
K
K
Fujiwara
M
M
Orito
K
K
D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000378:metabolism; D000983:Antipyrine / Q000378:metabolism; D019540:Area Under Curve; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004285:Dogs; D004334:Drug Administration Schedule; D004789:Enzyme Activation / Q000187:drug effects*; D006207:Half-Life; D008099:Liver / Q000201:enzymology; D010634:Phenobarbital / Q000008:administration & dosage* / Q000378:metabolism*
D000927:Anticonvulsants; D003577:Cytochrome P-450 Enzyme System; D000983:Antipyrine; D010634:Phenobarbital